Medidata Blog
Collecting Clinical Data, RBM, Study Design and More… Medical Device and Pharma Perspectives
August 08, 2016
Reading Time: < 1 minute
How are clinical studies conducted by medical device companies different from pharma studies? Is the way clinical data is collected or risk-based monitoring and critical processes conducted similar? Medtronic International’s Nurcan Coskun shares her thoughts, in this video conclusion.
Watch Part 1 of our video interview with Medtronic International's Nurcan Coskun.
*Guest blogger Nurcan Coskun is the district monitoring manager across Europe for clinical operations at Medtronic International.
TWEET THIS:
[VIDEO] Collecting #Clinical Data, RBM, Study Design and More… Medical Device and #Pharma Perspectives http://t.co/9ACl4fASKf
— Medidata (@Medidata) January 30, 2015
